# A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

> **NCT00029341** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 36 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BEHAVIORAL:** Treatment Interruption

## Key facts

- **NCT ID:** NCT00029341
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (—)
- **Last updated:** 2008-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00029341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00029341, "A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00029341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*